Industries > Pharma > Asia Vaccines Market Forecast to 2029

Asia Vaccines Market Forecast to 2029

Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Influenza, Hepatitis, Polio, Meningococcal, DTP, Rotavirus, MMR, HPV

PUBLISHED: 28 October 2019
PAGES: 178
PRODUCT CODE: PHA0554
SUBMARKET: Regional Markets

Clear
WOOCS 2.2.1
SKU: PHA0554 Categories: , Tags: , ,

Asia vaccines market is estimated at $7bn in 2018 and is expected to grow at a CAGR of 8.8% during the first half of the forecast period. The Japanese vaccines market held 30% share of the Asian vaccines market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 178-page report you will receive 82 charts– all unavailable elsewhere.

The 178-page report provides clear detailed insight into the Asian vaccines market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Asia Vaccines Market revenue forecasts to 2029

• Asia Vaccines Market revenue forecasts to 2029 by Vaccine Technology:
• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines

• Asia Vaccines Market revenue forecasts to 2029 by Indication:
• Influenza
• Hepatitis
• Polio
• Meningococcal
• DTP
• Rotavirus
• MMR
• HPV
• Others

Asia Vaccines Market Forecast to 2029

• Asia Vaccines Market revenue forecasts to 2029 by Country:
• Japan
• China
• India
• Australia
• South Korea
• Vietnam
• Philippines
• Thailand
• Indonesia
• Rest of Asia

Further segmented by indication and vaccine technology.

• Profiles of the selected leading companies:
• Astellas
• AstraZeneca
• CSL, Ltd.
• Emergent BioSolutions, Inc.
• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Mitsubishi Tanabe Pharma Corporation
• Pfizer
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Sun Pharmaceuticals Industries, Ltd.
• Takeda

• This report provides a Pipeline Analysis

• This report discusses factors that drive and restrain the market. This report also discusses trends and opportunities in the market.

• Key Questions Answered by this Report:
• What is the current size of Asia vaccines market? How much will this market be worth from 2018 to 2029?
• What are the main drivers and restraints that will shape Asia vaccines market over the next ten years?
• What are the main segments within Asia vaccines market? How much will each of these segments be worth for the period 2018 to 2029? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the Asian vaccines market? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2029?
• Who are the leading companies and what are their activities, results, developments and prospects?

Visiongain’s study is intended for anyone requiring commercial analyses for Asia Vaccines Market. You find data, trends and predictions.

Buy our report today Asia Vaccines Market Forecast to 2029: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Influenza, Hepatitis, Polio, Meningococcal, DTP, Rotavirus, MMR, HPV.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Asia Vaccines Market Forecast to 2029


Download sample pages

Complete the form below to download your free sample pages for Asia Vaccines Market Forecast to 2029


Latest Pharma news

The Global Wound Care Market Is Set to Boom, Particularly in Emerging Economies

The global wound care market is big, and only set to grow bigger.  Currently, estimates show a CAGR of 4.6% in the years to come, with the overall market growing from US$19.8 billion in 2019 to US$24.8 billion by 2024.  The industry is ripe with opportunity, with that growth coming from several factors – but most especially growth in emerging …

30 March 2020

READ

“The global nasal drug delivery technology market is estimated to have reached $44,385 million in 2019” says new Visiongain report

Nasal Sprays segment held the largest market share of the global nasal drug delivery technology market in 2019.

30 March 2020

READ

“Global Stem Cell Technologies and Applications market set to grow to $10903.0m by 2025” says new Visiongain report

New technologies will be needed to ensure that scaling-up of manufacturing operations can be done effectively once stem cell treatments enter the market.

24 March 2020

READ

Visiongain publishes Novel Coronavirus (COVID-19) Drugs in Development Market Forecast 2020-2030 report

As per the latest reports of UNCTAD (United Nations Conference on Trade and Development), COVID-19 pandemic has not only led to tragic human consequences but is projected to cost the global economy $1 trillion in 2020.

24 March 2020

READ

Categories

Category